Needham & Company Downgrades Theravance Biopharma (TBPH) to Hold, Following Strategic Business Update

Go back to Needham & Company Downgrades Theravance Biopharma (TBPH) to Hold, Following Strategic Business Update
(NASDAQ: TBPH) Delayed: 16.97 +0.05 (0.30%)
Previous Close $16.92    52 Week High $38.92 
Open $16.91    52 Week Low $12.87 
Day High $16.99    P/E N/A 
Day Low $16.91    EPS $0.00 
Volume 405,435